Heikki Relas

Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins

Tatu A. Miettinen, Helena Gylling, Nina Lindbohm et al. · Journal of Laboratory and Clinical Medicine · 2003 · 107 citations

Life Sciences, Biochemistry, Pharmacology +12

Rates of Serious Infections and Malignancies Among Patients with Rheumatoid Arthritis Receiving Either Tumor Necrosis Factor Inhibitor or Rituximab Therapy

Kalle Aaltonen, J. Joensuu, Liisa Virkki et al. · The Journal of Rheumatology · 2015 · 80 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Ulf Lindström, Daniela Di Giuseppe, Bénédicte Delcoigne et al. · Annals of the Rheumatic Diseases · 2021 · 54 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Mikkel Østergaard, Ronald van Vollenhoven, Anna Rudin et al. · Annals of the Rheumatic Diseases · 2023 · 52 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Outcomes of switching anti-TNF drugs in rheumatoid arthritis—a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN)

Liisa Virkki, Heikki Valleala, Yuya Takakubo et al. · Clinical Rheumatology · 2011 · 51 citations

Medicine, Internal Medicine, Pharmacotherapy +13